[Use of somatostatin in the conservative treatment of external pancreatic fistula].
We present six cases of postoperative pancreatic fistulas treated with complete diet and total parenteral nutrition. Due to the slow closure of the fistula, we added somatostatin to treatment (doses specified in the report). Flow disappeared completely in all cases, and the fistula was successfully closed in 5 of the 6 cases. There were no side effects due to the medication. We emphasize that the results of somatostatin treatment were favorable, achieving early closure of the fistula and reducing the complications derived from it.
Fernández Balaguer
P
P
Suárez Miguelez
J M
JM
Galeano Díaz
F
F
Hernández Antequera
E
E
Asensio Prianes
L
L
Urquijo Tomatti
H
H
Rodelgo Lozano
M
M
García-Sancho Martín
L
L
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D005402:Fistula / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010185:Pancreatic Fistula / Q000188:drug therapy / Q000628:therapy*; D010289:Parenteral Nutrition, Total; D011183:Postoperative Complications / Q000188:drug therapy / Q000628:therapy*; D012871:Skin Diseases / Q000188:drug therapy / Q000628:therapy*; D013004:Somatostatin / Q000008:administration & dosage / Q000627:therapeutic use*
D013004:Somatostatin
Empleo de la somatostatina en el tratamiento conservador de fístulas pancreáticas externas.